Charles Schwab Investment Management Inc Nex Immune, Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.61 - $4.68 $59,784 - $173,782	-37,133 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.11 - $15.13 $9,974 - $36,720	-2,427 Reduced 6.13%	37,133 $172,000
Q3 2021 Nov 16, 2021	SELL	$10.32 - $16.9 $21,775 - $35,659	-2,110 Reduced 5.06%	39,560 $599,000
Q2 2021 Aug 16, 2021	SELL	$14.98 - $23.89 $47,127 - $75,157	-3,146 Reduced 7.02%	41,670 $681,000
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $804,447 - $1.16 Million	44,816 New	44,816 $856,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.